HEALTH & MEDICINE
A New Dawn: Health Canada Approves Second Drug to Slow Alzheimer’s Progression
The landscape of dementia care in Canada reached a significant turning point in 2026. Following the landmark approval of lecanemab (Leqembi) in late 2025, Health Canada…